Rasagiline mesylate

Rasagiline mesylate is used to treat Parkinson’s disease, either alone or with levodopa. It works by inhibiting MAO-B, increasing dopamine levels in the brain. This helps reduce motor symptoms like tremor, stiffness, and “off” episodes. It may also have potential neuroprotective effects, though not clinically confirmed. It is grouped under the following drug class(es): Dopamine agents and Neurotransmitter agents. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Azilect, Agilect and Rasagiline methanesulfonate. Its PubChem CID is 3052775.

CAS No 161735-79-1
Molecular Formula C13H17NO3S
Molecular Weight 267.35 g/mol
Synonyms methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine

Frequently Asked Questions